Common Synapse

Founder-led consulting for life sciences leaders operating across CH/UK/EU. Fixed-scope (2–4 week) decision sprints that validate decision-critical assumptions using anonymised patient-lived evidence from global public online conversations and digital insights. Delivered as concise, defensible briefs for cross-border fundraising narratives, partnering readiness and investor/board discussions.

  • Established 2026
  • Individual enterprise
  • 1-10 employees

Country Focus

  • Norway
    Location Type
    No office/partner in the country
    Certification
    -

  • Denmark
    Location Type
    No office/partner in the country
    Certification
    -

  • Sweden
    Location Type
    No office/partner in the country
    Certification
    -

  • France
    Location Type
    No office/partner in the country
    Certification
    -

  • Germany
    Location Type
    No office/partner in the country
    Certification
    -

  • United Kingdom
    Location Type
    No office/partner in the country
    Certification
    -

Sector Focus

  • Biotechnology
    Sector association
    -
    Certification
    -
  • Pharmaceutics
    Sector association
    -
    Certification
    -

Services

  • Communication Strategy
    Description
    Cross-border narrative & comms strategy grounded in patient online conversations
    Professional association
    -
    Certification
    -
  • Company Strategy
    Description
    Company strategy support grounded in patient online conversations
    Professional association
    -
    Certification
    -
  • Marketing Strategy
    Description
    Patient-lived evidence from online conversations for biotech decision support.
    Professional association
    -
    Certification
    -

Case Studies, Studies, Publications, Certificates

References, Recommendation Letters